Weight Loss Outcomes With Telemedicine During COVID-19.
Front Endocrinol (Lausanne)
; 13: 793290, 2022.
Article
in En
| MEDLINE
| ID: mdl-35360066
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Telemedicine
/
Anti-Obesity Agents
/
COVID-19
Type of study:
Observational_studies
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Front Endocrinol (Lausanne)
Year:
2022
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Suiza